Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-26-116204
Filing Date
2026-03-19
Accepted
2026-03-19 17:17:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d114175d424b3.htm 424B3 324011
2 GRAPHIC g114175g0317104107520.jpg GRAPHIC 4525
3 GRAPHIC g45630g52z59.jpg GRAPHIC 2897
4 GRAPHIC g45630g79v93.jpg GRAPHIC 4656
  Complete submission text file 0001193125-26-116204.txt   342373
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 26775223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)